Every Form 4 that Precigen, Inc. (PGEN) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PGEN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PGEN filings page.
PRECIGEN, INC. director Nancy H. Agee received equity-based compensation on March 10, 2026. She was granted 35,612 restricted stock units, each representing one share of common stock, which vest in full on March 10, 2027. She also received an option to purchase 41,073 shares of common stock at an exercise price of $3.51 per share, expiring on March 10, 2036. In addition, she was issued 16,096 shares of common stock in lieu of an annual cash retainer of $56,500. Following these awards, her directly held common stock position reported in this filing is 233,937 shares.
A director of Precigen, Inc. reported selling 235,467 shares of common stock on 12/12/2025. The shares were sold at a weighted average price of $3.6349, with individual trades executed at prices ranging from $3.5000 to $3.7100.
Following these sales, the director beneficially owns 110,603 shares of Precigen common stock in direct ownership. The filing notes that full details of the number of shares sold at each price within the stated range are available upon request.
Precigen, Inc. (PGEN) reported insider activity by director and 10% owner Randal J. Kirk on a Form 4. Through entity Kapital Joe, he sold 1,086,153 shares of common stock on 11/19/2025 at a weighted average price of $4.47, 942,832 shares on 11/20/2025 at a weighted average price of $4.08, and 937,308 shares on 11/21/2025 at $3.83.
The filing notes that the first two prices are weighted averages for multiple trades within reported price ranges, and Kirk undertakes to provide full trade details on request. After these sales, he continues to report large indirect beneficial ownership positions in Precigen through multiple entities, including 7,434,384 shares held by Kapital Joe and 82,164,767 shares held by R.J. Kirk Declaration of Trust, along with additional holdings through various family and investment vehicles.